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Mass Spectrometry– based Proteomic Analysis
of the Matrix Microenvironment in Pluripotent
Stem Cell Culture*□
S

Chris Hughes‡, Lida Radan§, Wing Y. Chang¶, William L. Stanford¶, Dean H. Betts§,
Lynne-Marie Postovit储, and Gilles A. Lajoie‡**
The cellular microenvironment comprises soluble factors, support cells, and components of the extracellular
matrix (ECM) that combine to regulate cellular behavior.
Pluripotent stem cells utilize interactions between support cells and soluble factors in the microenvironment to
assist in the maintenance of self-renewal and the process
of differentiation. However, the ECM also plays a significant role in shaping the behavior of human pluripotent
stem cells, including embryonic stem cells (hESCs) and
induced pluripotent stem cells. Moreover, it has recently
been observed that deposited factors in a hESC-conditioned matrix have the potential to contribute to the reprogramming of metastatic melanoma cells. Therefore,
the ECM component of the pluripotent stem cell microenvironment necessitates further analysis.
In this study we first compared the self-renewal and
differentiation properties of hESCs grown on Matrigel™
pre-conditioned by hESCs to those on unconditioned
Matrigel™. We determined that culture on conditioned
Matrigel™ prevents differentiation when supportive
growth factors are removed from the culture medium. To
investigate and identify factors potentially responsible for
this beneficial effect, we performed a defined SILAC MSbased proteomics screen of hESC-conditioned Matrigel™. From this proteomics screen, we identified over 80
extracellular proteins in matrix conditioned by hESCs and
induced pluripotent stem cells. These included matrixassociated factors that participate in key stem cell pluripotency regulatory pathways, such as Nodal/Activin and
canonical Wnt signaling. This work represents the first
investigation of stem-cell-derived matrices from human
pluripotent stem cells using a defined SILAC MS-based
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The two defining characteristics of human embryonic stem
cells (hESCs),1 self-renewal and pluripotency, are maintained
by a delicate balance of intracellular and extracellular signaling processes. Extracellular regulation is primarily the result of
changes in the microenvironment surrounding the cells during
growth in vitro or in vivo. HESCs interact with this “niche ”
through support cells, extracellular matrix (ECM) components,
and autocrine/paracrine signaling (reviewed in Refs. 1–3).
Modulation of any of these supportive elements individually or
in combination has been used extensively to alter hESC behavior (1–3).
The culture of hESCs, as well as that of human induced
pluripotent stem cells (hiPSCs), is conventionally performed
on a layer of irradiated mouse embryonic fibroblast cells
(MEFs). These MEFs are believed to promote the maintenance
of hESCs and hiPSCs through the secretion of beneficial
support proteins and cytokines into the soluble microenvironment. A number of proteomic studies have been conducted
that examine the secretome of feeder-cell layers in an attempt
to elucidate proteins and pathways essential for hESC and
hiPSC survival (4 –7). Alternatively, hESCs and hiPSCs can be
cultured in feeder-free conditions in the absence of support
cells. In feeder-free conditions, hESCs and hiPSCs are most
often grown on the basement membrane matrix Matrigel™ in
medium that has been previously conditioned by MEFs (MEFCM). Matrigel™ is a gelatinous mixture that is secreted by
Engelbreth-Holm-Swarm mouse sarcoma cells (8). Although
recent studies have proposed that a variety of defined matri1

The abbreviations used are: BMP, bone morphogenic protein;
CM, conditioned medium; CTGF, connective tissue growth factor;
DMEM, Dulbeccos’ modified Eagle’s medium; ECM, extracellular matrix; FBS, fetal bovine serum; FGF, fibroblast growth factor; hESC,
human embryonic stem cell; hiPSC, human induced pluripotent stem
cell; Lefty, left-right determination factor; MEF, mouse embryonic
fibroblast; PBS, phosphate buffered saline; sFRP, soluble frizzled
related protein; SILAC, stable isotope labeling with amino acids in cell
culture; SMAD, SMA mothers against decapentalegic; SSEA, stagespecific embryonic antigen; TGF, transforming growth factor.
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ces can support the growth of hESCs and hiPSCs, few of
these can maintain a wide range of stem cell lines and therefore are typically not used in place of Matrigel™. The properties of Matrigel™ that make it such an effective matrix for
hESC and hiPSC culture remain poorly understood. Because
of the complexity of matrices like Matrigel™, the majority of
proteomic studies that examine the hESC and hiPSC microenvironment have focused on contributions from support
cells and soluble extracellular factors.
The ECM is typically a complex network of structural proteins and glycosaminoglycans that function to support cells
through the regulation of processes such as adhesion and
growth factor signaling (9). Thus, it is not surprising that the
generation of a well-defined matrix capable of facilitating
hESC and hiPSC self-renewal has remained difficult (10). Previous proteomic investigations of Matrigel™ and other matrices supportive of hESC maintenance in vitro have revealed
the presence of numerous growth, binding, and signaling
proteins (11, 12). Further examination of how hESCs and
hiPSCs interact with these complex matrices would provide
critical information about what role the ECM plays in the
organization of processes involved in the regulation of selfrenewal and pluripotency.
A recent study has established the ability of hESC-derived
matrix microenvironments to alter tumorigenic properties
through the reprogramming of metastatic melanoma cells
(13). Importantly, this effect was found to be dependent on the
exposure of metastatic cells to hESC-derived conditioned
Matrigel™. Culture of metastatic melanoma cells in hESCconditioned medium did not promote the reprogramming effect. These data suggest that the proteins responsible for this
effect were integrated in the matrix. With the use of immunochemical techniques, it was later found that the left-right
determination (Lefty) proteins A and B that were deposited in
the matrix by hESCs during conditioning were at least in part
responsible for the cellular change observed in metastatic
cells (14). The Lefty A and B proteins are antagonists of
transforming growth factor (TGF)-␤ signaling that act directly
on Nodal protein, a critical regulator of the stem cell phenotype (15, 16). Subsequent studies of conditioned matrix utilizing mESCs implicated the bone morphogenic protein (BMP)
4 antagonist Gremlin as a primary regulator of the observed
changes in metastatic cells (17). Collectively, these studies
were all biased by a targeted analysis of potential effectors of
metastatic cells. A comprehensive proteomic analysis of conditioned matrix could potentially reveal other factors involved
in metastatic cell reprogramming. Furthermore, proteomic examination of hESC and hiPSC conditioned matrix could expose factors important in the regulation of self-renewal and
pluripotency by the microenvironment in vitro.
To this end, we have analyzed both types of human pluripotent stem cells, hESCs and hiPSCs, via a mass spectrometry (MS)-based proteomics approach to identify proteins deposited during growth in feeder-free conditions in vitro on
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Matrigel™. To investigate the hESC- and hiPSC-derived matrix, the metabolic labeling technique known as stable isotope
labeling with amino acids in cell culture (SILAC) was used (18).
SILAC facilitates the identification of hESC- and hiPSC-derived proteins that would otherwise be confounded by the
presence of mouse-derived protein background from Matrigel™. From the proteomic analysis of three cells lines,
namely, the hESC lines H9 and CA1 and the hiPSC line BJ-1D,
we identified a total of 621, 1355, and 1350 total unique
proteins, respectively. This work represents the first analysis
of a hESC- and hiPSC-derived conditioned matrix and resulted in the identification of at least one novel microenvironmental contributor responsible for the regulation of human
pluripotent stem cells.
EXPERIMENTAL PROCEDURES

Cell Culture and Harvest—H9 (passage 26) and CA1 (passage 20)
hESCs and BJ-1D (passage 69) hiPSCs were maintained on CF-1
irradiated MEF feeder layers (GlobalStem, Rockville, MD) using media
composed of knockout DMEM/F12, 20% knockout serum replacement, 1% non-essential amino acids, 2 mM glutamine (CellGro, Manassas, VA), 0.1 mM 2-mercaptoethanol (Fisher, Toronto, ON, Canada), and 4 ng/ml of basic fibroblast growth factor (bFGF). Irradiated
MEF feeder layers were seeded at a density of 2 ⫻ 105 cells/well in a
six-well dish. During MEF culture, hESCs and hiPSCs were passaged
mechanically when they reached 70% confluency (⬃6 days after
plating). For feeder-free growth, standard hESC medium that was
conditioned on a layer of irradiated MEF feeders (MEF-CM) was used
with plates coated with Matrigel™ (BD Biosciences, Franklin Lake,
NJ). For general feeder-free growth, culture dishes were coated with
a 1:30 dilution of Matrigel™ in DMEM/F12. Prior to use, MEF-CM was
supplemented with an additional 8 ng/ml of bFGF and filtered. During
feeder-free culture, hESCs and hiPSCs were passaged mechanically
when they reached 70% confluency (⬃6 days after plating). H9
hESCs were obtained from WiCell (Madison, WI). The CA1 hESC line
used in all experiments was obtained from Dr. Cheryle Seguin of the
University of Western Ontario (19, 20). The hiPSC line BJ-1D was
derived by reprogramming using retroviral transduction of BJ fibroblasts with the Yamanaka factors essentially as we have described
elsewhere (21) and validated as pluripotent using in vitro and in vivo
differentiation assays and expression profiling (unpublished results).
Cells were fed every 24 h in both feeder-dependent and feeder-free
conditions.
For SILAC experiments, hESC and hiPSC cell lines were grown in
feeder-free conditions on Matrigel™ (BD Biosciences, Franklin Lake,
NJ). Custom DMEM/F12-glutamax that contained no L-arginine or
L-lysine was ordered from Invitrogen and used in all SILAC experiments. Culture dishes were coated with 1:30 dilutions of Matrigel™ in
DMEM/F12 containing no L-arginine or L-lysine. Complete SILAC
medium was prepared using the StemPro® hESC Media system
(Invitrogen) according to the manufacturer’s instructions, substituting
the provided basal medium with the arginine- and lysine-free custom
DMEM/F12. [13C6, 15N4]-L-arginine and [13C6, 15N2]-L-lysine (Cambridge Isotope Laboratories, Andover, MA) were supplemented into
the SILAC medium at 90 mg/L and 92 mg/L, respectively. Unlabeled
L-proline was added to the SILAC medium at a final concentration of
800 mg/L (22). During feeder-free maintenance in SILAC medium,
cells were passaged mechanically when they reached 80% confluency (⬃4 days after plating). Cells were fed every 24 h in feeder-free
conditions with SILAC medium.

1925

Proteomics of Human Stem Cell Derived Matrices

Embryoid bodies (EBs) were generated in all cases using Aggrewell
400Ex plates (StemCell Technologies, Vancouver, BC, Canada) according to the manufacturer’s instructions. Briefly, ⬃2 ⫻ 106 hESCs
or hiPSCs were harvested enzymatically using Accutase (Invitrogen)
from Matrigel™-coated plates. As Accutase will generate a single cell
suspension, hESCs and hiPSCs were reconstituted in Aggrewell medium (StemCell Technologies) supplemented with ROCK inhibitor
(Y-27632) (Sigma-Aldrich, St. Louis, MO) at a final concentration of 10
M to promote aggregation. After plating in Aggrewell dishes, EBs
were grown for 48 h at 37 °C prior to transfer to ultra-low adherence
tissue culture dishes (Corning, Lowell, MA). EBs were fed every 2 to
3 days with fresh Aggrewell medium not supplemented with ROCK
inhibitor. After 15 days of culture, EB RNA was harvested using Trizol
extraction according to the manufacturer’s instructions (Invitrogen).
EBs were assayed for expression of CDX2, alpha-feto protein,
GATA-6, GATA-4, Oct3/4, PAX-6, T-brachyury, Nanog, and Neurogenic differentiation 1 using TaqMan primer probe sets (Invitrogen).
Details of these assays can be found in supplemental Table S7. All EB
assays were performed in biological and technical duplicate for each
cell line and each condition.
Generation and Harvest of Conditioned Matrix—To generate labeled populations of stem cells, H9, CA1, or BJ-1D cells were grown
in feeder-free conditions on Matrigel™ in heavy-isotope ([13C6, 15N4]13
15
L-arginine and [ C6,
N2]-L-lysine) containing SILAC medium for 7
days (about four population doublings). Small colonies (⬃5 to 10 cells
based on visual inspection) generated using mechanical passaging
were plated at low confluency (⬃10%) to prevent overgrowth during
the 7-day labeling phase. After the 7-day labeling period, hESC and
hiPSC lines were harvested to determine isotopic label incorporation.
Alternatively, hESCs or hiPSCs were mechanically passaged to Matrigel™-coated (1:10 dilution) dishes for the generation of the conditioned matrix. In this case, small (⬃5 to 10 cells) hESC or hiPSC
colonies were passaged to the Matrigel™-coated dishes to result in a
confluency of ⬃40% 24 h after plating. This was done to maximize the
surface of the dish covered by hESCs and hiPSCs at harvest without
compromising stem cell phenotype due to overconfluent dishes. Labeled stem cells were allowed to grow for a period of 5 days in
Matrigel™-coated wells in heavy-isotope-containing SILAC medium.
After this growth period, hESCs and hiPSCs were typically ⬃90%
confluent on the Matrigel™ layer.
Prior to harvest of the conditioned Matrigel™, wells were rinsed
thoroughly with PBS to ensure removal of medium components. Cells
were removed from the conditioned Matrigel™ layer using a commercial matrisperse mixture called Cell Recovery Solution (BD Biosciences) according to the manufacturer’s instructions. The collected
Cell Recovery Solution containing the hESCs or hiPSCs was spun for
10 min at 10,000g to pellet the cells. The stem cells in this pellet were
examined through RT-PCR, flow cytometry, and EB assays. The
remaining conditioned Matrigel™ layers were rinsed thoroughly with
PBS to remove any residual cell debris. The conditioned Matrigel™
layers were examined manually to ensure complete cell removal. The
remaining conditioned Matrigel™ layer was incubated in a solution
containing 8 M urea, 100 mM ammonium bicarbonate, and 1 M NaCl
for 24 h at 4 °C. This harvested conditioned Matrigel™ solution was
concentrated using high-capacity C18 cartridges (Phenomenex, Torrance, CA). Eluted components were dried using a SpeedVac and
reconstituted in 8 M urea with 100 mM ammonium bicarbonate prior to
fractionation. Stem-cell-conditioned Matrigel™ was generated and
analyzed in biological and technical duplicate or greater for each cell
line (H9, n ⫽ 3; CA1, n ⫽ 3; BJ-1D, n ⫽ 2).
For examination of stem cell growth and pluripotency on hESCconditioned Matrigel™, layers were prepared as above with minor
alterations. Briefly, hESCs were grown in feeder-free conditions on
Matrigel™ (1:30 dilution) in MEF-CM. hESCs were passaged mechan-
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ically as small colonies (⬃5 to 10 cells) to Matrigel™-coated (1:10
dilution) dishes to generate a confluency of ⬃30% 24 h after plating.
hESCs were maintained on this Matrigel™ layer in MEF-CM for 5 days
(⬃70% confluent after this period) to produce the conditioned Matrigel™. Layers of conditioned Matrigel™ were rinsed and cells were
removed as described above. Fresh hESCs grown in feeder-free
conditions on Matrigel™ in MEF-CM were mechanically passaged to
the conditioned Matrigel™ layers to produce a confluency of ⬃30%
24 h after plating. During the first 24 h, hESCs were fed with MEF-CM.
After this initial phase, the culture medium was changed to EB medium and fed daily. EB medium has the same composition as standard hESC media used for growth on MEF feeders as outlined above,
minus bFGF. The absence of bFGF in this formulation will result in
undirected hESC differentiation. After 4 days of growth in EB medium,
hESCs were examined for pluripotency marker expression using RTPCR, Western blotting (see “Methods” in the supplementary material),
flow cytometry, and immunofluorescence (see “Methods” in the supplementary material).
MS Analysis—Samples of harvested conditioned Matrigel™ were
subjected to fractionation with 1D-SDS-PAGE and subsequently digested using an in-gel protocol with trypsin (see “Methods” in the
supplementary material). Alternatively, conditioned Matrigel™ samples were digested using an in-solution protocol with trypsin and
subjected to fractionation with strong anion exchange or strong cation exchange columns packed in-house (see “Methods” in the supplementary material). Prepared fractions were injected and separated
using a nanoAcquity system (Waters, Milford, MA) equipped with a 25
cm ⫻ 75 m inner diameter C18 column. Fractions were separated
using a 1% to 40% acetonitrile gradient over 150 min at a flow rate of
300 nL/min. MS analysis was done on a Q-ToF Ultima (Micromass/
Waters) using data-dependent acquisition with selection of the four top
precursor masses per survey scan. Survey scans were set at 1 s, and
MS/MS acquisition was set at 1 s or 8000 cps TIC cut-off. Exclusion lists
were generated using in-house software that automatically added 0.7
amu to the precursor masses selected in previous runs and output a file
also containing retention time information. Each fraction was analyzed
for four exclusion rounds (five injections total), with the injection volume
adjusted depending on signal intensity in the MS survey scan.
Proteomic Data Analysis—Data analysis for all samples was performed with PEAKS 5.3 software (Bioinformatics Solutions Inc., Waterloo, ON, Canada) (23, 24). After being imported into PEAKS,
MS/MS spectra from raw data files were refined using the following
settings: merge spectra - true (100 ppm mass tolerance, 60 s retention time tolerance), correct precursor mass - true, determine precursor charge state - true (minimum charge ⫹2, maximum charge ⫹5),
spectral quality filter - true (0.65 threshold), centroid, deisotope, and
deconvolute - true. Resulting MS/MS spectra were then de novo
sequenced using the following parameters: parent monoisotopic
mass tolerance, 100 ppm; fragment monoisotopic mass tolerance,
0.15 Da; enzyme specificity, semi-Trypsin; fixed modifications, carbamidomethylation, ⫹10 Da on Arginine and ⫹8 Da on Lysine for
SILAC; and variable modifications, N-terminal acetylation and oxidized methionine. After de novo analysis, data were searched against
the UniProt sequence database (updated December 2011; Human
taxonomy specified, 20,236 total entries, or Mouse taxonomy specified, 16,376 total entries) using the following parameters: parent
monoisotopic mass tolerance, 100 ppm; fragment monoisotopic
mass tolerance, 0.15 Da; enzyme specificity, semi-Trypsin (two
missed cleavages permitted); fixed modifications, carbamidomethylation, ⫹10 Da on arginine and ⫹8 Da on lysine for SILAC; variable
modifications, N-terminal acetylation and oxidized methionine; and
estimate false-discovery rate - true.
The resultant proteins identified from the database search were
further processed using PEAKS 5.3 software. Proteins were filtered by
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FIG. 1. Generation of samples for hESC-conditioned Matrigel™ analysis. A, untreated Matrigel™ samples were generated by plating
hESCs on a Matrigel™ layer and harvesting after 4 days of growth in MEF-CM. B, control Matrigel™ samples were generated by treating a
Matrigel™ layer with cell recovery solution (see Experimental Procedures) and plating hESCs on this layer. hESCs were recovered from the
treated layer after 4 days of growth in EB medium. C, conditioned Matrigel™ samples were produced by plating hESCs on a Matrigel™ layer
and culturing for 4 to 5 days in MEF-CM. hESCs were subsequently removed from this layer using cell recovery solution to produce conditioned
Matrigel™. Fresh hESCs were plated on the conditioned Matrigel™ layer and grown for 4 days in EB medium.
assigned score to give a ⬍1.0% false-discovery rate for peptide
matches based on estimation from a decoy-fusion method of database searching (24). Identified proteins were also required to be
derived by at least two unique peptides. Proteins that contained
overlapping peptides were grouped. Within each group, only the
highest scoring member was reported when differentiation based on
unique peptides could be made. When proteins could not be distinguished, they were all reported, as members of the same group. For
all samples analyzed, keratin hits were manually removed from the
final datasets. All raw peptide identifications can be found in supplemental Tables S8 –S10. Gene ontology analysis was performed using
STRAP software (CPC Tools) (25). The data associated with this
manuscript may be downloaded from the ProteomeCommons.org
Tranche network using the following hash: FB/HM1WSAUo4uZ/
QX8FDnyxRqsq⫹xl7lFV5A4ri4Eik0px38w20CBv3E3WdmuIu1IF9ANs
ZGhpOdEHlcAxk⫹Q⫹MJr9gAAAAAAAAo/Q ⫽ ⫽ .
Real-time PCR—RNA was purified using Trizol reagent according
to the manufacturer’s instructions (Invitrogen) with the following modification: precipitated RNA pellets in isopropanol were centrifuged for
60 min at 12,000g at room temperature. After NanoDrop quantification,
1 g of cDNA was synthesized using the High Capacity cDNA Reverse
Transcription Kit with RNase inhibitor (Invitrogen). Real-time PCR was
performed using the TaqMan® Universal PCR Master Mix (Invitrogen).
Samples were incubated at 50 °C for 2 min followed by 10 min at 95 °C.
DNA was then amplified at 95 °C for 15 s followed by 1 min at 58 °C for
46 cycles. All samples were normalized to large ribosomal protein
RPLPO. All primers were obtained from Invitrogen, and details of these
assays can be found in supplemental Table S7. Each biological replicate
was run in triplicate for every marker assayed. All reagents were used
according to the manufacturer’s instructions.
Flow Cytometry—All reagents and probes for flow cytometry were
obtained from eBiosciences (San Diego, CA) unless otherwise noted.
Cells were enzymatically harvested using Accutase (Invitrogen) to
obtain a single cell suspension. After centrifugation, cell pellets were
resuspended in 5% FBS in PBS. Alexa-488 conjugated SSEA-4 and
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Alexa-647 conjugated SSEA1 were diluted into the cell mixture according to the manufacturer’s instructions. Negative control samples
contained respective isotype controls for the primary antibodies used.
Solutions were incubated for 2 h and analyzed using an Accuri C6 (BD
Biosciences) flow cytometer after rinsing to remove unbound antibody.
Populations were gated according to forward and side scatter patterns
with filtering for viable cells using 7-aminoactinomycin D staining. Data
were analyzed using FlowJo software (Tree Star, Ashland, OR).
Statistical Analysis—Statistical analyses were performed using
GraphPad Prism software. Results are expressed as S.D. or S.E. as
indicated in figure legends. Statistical significance was determined
using one-way ANOVA with Tukey post hoc. Differences were reported as follows: * p ⬍ 0.05, ** p ⬍ 0.01, *** p ⬍ 0.001.
RESULTS

hESC-derived Matrix for the Maintenance of an Undifferentiated State—The ability of embryonic microenvironments to
suppress the tumorigenic phenotype has been previously illustrated in a number of developmental and cellular systems
(reviewed in Ref. 26). Analogous to metastatic cells, embryonic stem cells can direct cellular changes in response to
cues from their microenvironment. Given the recent observation that a hESC-derived matrix microenvironment could
modulate the behavior of metastatic cells (14), we sought to
determine what effect exposure would have on the stem cell
phenotype. To this end, we monitored changes in the gene
and protein expression of hESCs grown on conditioned Matrigel™ in the absence of exogenous growth factor supplementation (Figs. 1A–1C). In this way, matrix-dependent changes in
hESC behavior could be monitored without interference from
soluble factors present in MEF-CM.

1927

Proteomics of Human Stem Cell Derived Matrices

FIG. 2. hESC-conditioned Matrigel™ enhances the maintenance of an undifferentiated state in H9 cells relative to those grown on
control Matrigel™. Untreated, control, and conditioned Matrigel™ hESC samples were generated as described in Fig. 1 and the Experimental
Procedures section. A, RT-PCR data for H9 hESCs grown on the three separate matrix conditions. Values represent fold change of Oct3/4 or
Nanog expression relative to untreated Matrigel™ samples. RPLPO was used as an internal control for all samples. Error bars represent S.E.,
n ⫽ 3. B, Western blot for Oct3/4 and Nanog in H9 hESCs grown on the different matrices. Actin is shown as a control. C, flow cytometry data
for H9 hESCs grown on the different matrices. For each sample, plot (i) shows SSEA4 fluorescence (blue) relative to a matched isotype control
(solid red), (ii) shows SSEA1 fluorescence relative to isotype control, (iii) is a scatter plot with the gated cell population shown, and (iv) is a
scatter plot with the viable cell population gated. Percentages denote fractions of cells within the gates shown. D, results from flow cytometry
analysis of H9 hESCs grown on the different matrices for the markers SSEA4 and SSEA1. Values represent mean fluorescence intensity of
SSEA4 relative to SSEA1 for control Matrigel™ or conditioned Matrigel™ samples. Values are derived from the data in C. Error bars represent
S.E., n ⫽ 3. E, immunocytochemistry for H9 hESCs grown on control Matrigel™ or conditioned Matrigel™. Cells were stained with Oct3/4,
SSEA4, DAPI, and SSEA1. Scale bars represent 250 m.

After 4 days of culture in medium that contained no exogenous bFGF (EB medium), a decrease in POU5F1 (herein
referred to as Oct3/4) and Nanog gene and protein expression
were observed in H9 hESCs grown on control or conditioned
Matrigel™ relative to untreated cells. However, the observed
reduction in Oct3/4 and Nanog gene and protein expression
was significantly less in hESCs grown on conditioned Matri-
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gel™ than in those grown on control Matrigel™ (Figs. 2A and
2B). A similar trend was observed when H9 hESCs were
analyzed using flow cytometry for the expression of stagespecific embryonic antigen (SSEA) 4 and SSEA1, which are
expressed by undifferentiated and differentiated pluripotent
stem cells, respectively. H9 hESCs grown in EB medium on
conditioned Matrigel™ exhibited an increase in SSEA4 mean
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fluorescence intensity relative to SSEA1 when compared with
cells on control Matrigel™ (Figs. 2C and 2D). When cultures
were examined using immunofluorescence, pockets of
SSEA1-positive cells could be observed in colonies on control
Matrigel™ layers, indicating differentiation (Fig. 2E). SSEA1positive colonies were observed with a reduced frequency on
conditioned Matrigel™. Based on visual microscopy inspection, we did not observe an increase in cell death or growth
rate in the conditioned Matrigel™ cultures relative to the
control. Subsequent analysis of a second hESC line, CA1,
revealed similar trends (supplemental Figs. S1A–S1E). Taken
together, these data indicate that conditioned Matrigel™ promotes the preservation of an undifferentiated state and that
hESCs secrete factors into the matrix that are beneficial for
their own maintenance.
Proteomic Analysis of Pluripotent-Stem-Cell-Derived Conditioned MatrigelTM—To determine which factors are deposited by hESCs and hiPSCs during growth on Matrigel™, we
employed a global MS-based proteomics approach to analyze the corresponding conditioned Matrigel™. Previous studies that have illustrated the effects of conditioned Matrigel™
on metastatic cells have employed an NH4OH cellular lysis
protocol to remove hESCs from Matrigel™. Lysis of cells on
the matrix could potentially confound the proteomic analysis
by releasing high abundance intracellular proteins. To limit the
potential for intracellular protein contamination in the conditioned Matrigel™ resulting from lysis, we utilized a protocol
based on Matrigel™ de-polymerization to remove intact cells
from the matrix (see “Methods” in the supplementary material). Visual inspection via microscopy of the conditioned
Matrigel™ layers revealed that no intact cells remained on the
matrix after treatment with cell recovery solution. With this
method, the vast majority of the hESCs and hiPSCs that were
removed remained intact and viable, as indicated by 7-AAD
staining in flow cytometry (Fig. 3B). Additionally, the removal
of cell lysis from the protocol permitted analysis of the undifferentiated state and differentiation capacity of the cells that
deposited the matrix (Figs. 3A and 3C).
After cell removal and concentration of the conditioned
Matrigel™ solution, a combination of strong cation exchange,
strong anion exchange, and 1D-SDS-Gel methods (see
“Methods” in the supplementary material) were employed for
fractionation of the complex ECM-like mixture with iterative
exclusion MS analysis (12). MS analysis of these samples
illustrated the limited ability of our assay to determine hESCderived proteins in our list of identifications (supplemental
Figs. S2A and S2B). This limitation is a direct result of performing the conditioned matrix experiments on Matrigel™.
Because the mixture that is analyzed via MS represents a
combination of hESC-derived and Matrigel™ proteins, identification specificity is reliant on nonhomology between human and mouse proteins. However, when we searched the
dataset against a concatenated human and mouse sequence
database, we observed that few proteins were identified as
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belonging to a single species, indicating significant interspecies sequence similarity between the identified peptides (supplemental Figs. S2A and S2B). Many of the identified proteins
also were found in commercially prepared Matrigel™ in our
previous proteomic analysis (supplemental Figs. S2A and
S2B) (11). Taken together, these complications severely limited the specificity and sensitivity of the proteomic analysis.
To overcome these challenges, we employed the metabolic
labeling approach known as SILAC (18). We have adapted a
commercially available, fully defined, serum-free medium formulation to perform SILAC in hESCs and hiPSCs (27) that
builds on conditions previously optimized in our laboratory for
the application of SILAC with hESCs (22). After 10 passages in
SILAC medium (⬎60 days), H9, CA1, and BJ-1D stem cell
lines maintained expression for Oct3/4, Nanog, and SSEA4 as
indicated by RT-PCR, immunofluorescence, and flow cytometry (supplemental Figs. S3A–S3C). After the induction of
differentiation in vitro using EB assays, all cell lines exhibited
increased expression of markers characteristic of each of the
three primary germ layers (supplemental Fig. S3D). Additionally, H9 and CA1 hESCs also retained the ability to differentiate in vivo as observed using a teratoma assay (supplemental Fig. S3E; also see “Methods” in the supplementary
material). We observed an increase in growth rate in feederfree culture in SILAC medium (doubling time reduced to ⬃24
h in SILAC medium from ⬃30 h in MEF-CM), resulting in
⬎96% incorporation of the isotopic labels in just 7 days
(supplemental Fig. S4A). Additionally, there was no observable conversion of arginine to proline when utilizing the exogenous addition of L-proline to the SILAC medium as previously
reported (supplemental Figs. S4B and S4C) (22). Taken together, these data indicate that extended culture in StemPro®-based SILAC medium can maintain hESC and hiPSC
lines in an undifferentiated and pluripotent state. In addition,
this medium also represents one of the first fully defined
culture media applicable to SILAC experimentation with
hESCs and hiPSCs (28). In this SILAC approach, hESCs
and hiPSCs would be fully labeled with “heavy ” arginine and
lysine prior to being plated for the generation of conditioned
Matrigel™ (Fig. 4A). In this way, proteins that are deposited
during the generation of conditioned Matrigel™ carry a
“heavy” label and can easily be distinguished via MS from the
Matrigel™ proteins.
With this protocol, we analyzed conditioned Matrigel™ derived from H9 and CA1 hESCs, as well as BJ-1D hiPSCs. MS
analysis yielded a total of 621, 1355, and 1350 “heavy ”
labeled proteins identified from the H9, CA1, and BJ-1D cell
lines, respectively (Fig. 4B, supplemental Tables S1–S3). A
comparison of proteins identified between the cell lines indicated a ⬃30% overlap between the three datasets (Fig. 4B).
The gain in the number of proteins in the CA1 and BJ-1D stem
cell lines is due to their decreased stability in the StemPro®
SILAC medium. We observed an increase in cell death and
subsequent lysis during general growth of the CA1 and BJ-1D
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FIG. 3. Cell viability and pluripotency during generation and harvest of conditioned Matrigel™. H9 and CA1 hESCs and BJ-1D hiPSCs
were used to generate conditioned Matrigel™. After harvesting using a cell recovery method that minimizes lysis, remaining cells were assayed
for viability and markers of pluripotency. A, RT-PCR analysis of harvested cells for the markers Oct3/4 and Nanog. Values are relative to
undifferentiated cells grown in feeder-free conditions not exposed to the cell recovery harvesting methods. Error bars represent S.D., n ⫽ 3.
B, flow cytometry analysis of cells harvested using the cell recovery method. Cells were assayed for SSEA4 and SSEA1 surface marker
expression. Viability was determining using 7-AAD staining. C, cells harvested using the cell recovery method were used to generate embryoid
bodies. Following 15 days in culture, embryoid bodies were harvested and assayed for markers of pluripotency (Oct3/4, Nanog), trophoblast
(CDX2), ectoderm (NeuroD1, PAX6), endoderm (GATA4, GATA6, alpha-fetoprotein), and mesoderm (T). Error bars represent S.D., n ⫽ 2. Values
are fold change relative to undifferentiated cells. Phase contrast images of embryoid bodies are provided above. Scale bars represent 250 m.
In both A and C, RPLPO is used as a positive control.

cell lines relative to H9 hESCs in StemPro® SILAC medium,
resulting in the identification of additional intracellular proteins. However, we did not observe any significant differences
in growth rate or cell morphology between the hESC and
hiPSC cultures. Gene ontology analysis revealed that in the
dataset corresponding to each cell line, proteins representative of several cellular components were present. This suggests that a variable amount of cell lysis is occurring during
growth or harvest of the conditioned Matrigel™ for all the cell
lines.
To limit the contaminants from cell lysis, the dataset was
filtered using the “extracellular” and “cell surface” cellular
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component gene ontology terms. Filtering reduced the number of proteins identified in each dataset to 71, 100, and 95
labeled proteins for H9, CA1, and BJ-1D, respectively (Fig.
4B, supplemental Tables S4 –S6). However, the data still contained numerous intracellular proteins (histones, mitochondrial, and cytoskeleton associated). This was primarily the
result of the limited specificity of the gene ontology assignments. A comparison of the previously acquired commercial
Matrigel™ dataset (11) with gene ontology filtered conditioned Matrigel™ datasets revealed that 62%, 55%, and 50%
of proteins are identified in both matrices (Fig. 4C). These data
illustrate the necessity of SILAC when performing this analysis
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FIG. 4. Proteomic analysis of SILAC hESC- and hiPSC-derived conditioned Matrigel™. A, H9 and CA1 hESCs, and BJ-1D hiPSCs were
grown in defined SILAC medium containing [13C6, 15N4]-arginine and [13C6, 15N2]-lysine. After 7 days of culture, cells were passaged to culture
dishes precoated with Matrigel™. After 4 to 5 days of culture on Matrigel™ in SILAC medium containing the heavy isotopic labels, cells were
removed using a cell recovery method to minimize cell lysis. The remaining conditioned Matrigel™ layer was rinsed and harvested. Peptides derived
from hESCs will carry an isotopic label and will display a resultant mass shift in the MS, whereas those previously present in commercial Matrigel™
will not have this difference. B, conditioned Matrigel™ from H9 and CA1 hESCs and from BJ-1D hiPSCs was analyzed in biological triplicate using
an MS-based proteomics protocol. Numbers within the Venn diagrams represent the total number of protein identifications found in each
conditioned Matrigel™ analysis for the specific overlap. Datasets were also filtered using gene ontology classification for cellular components based
on the terms “extracellular” and “cell surface.” These values are represented in the lower Venn diagram. C, hESC and hiPSC conditioned Matrigel™
proteomic data were individually compared with those previously acquired for commercial Matrigel™ (11). Protein descriptions were used for
comparison, as identifiers are species specific. D, hESC and hiPSC conditioned Matrigel™ identifications were further compared with a secretome
dataset acquired through proteomic analysis of H9 hESC conditioned medium. Comparison was done manually based upon protein identifiers. In
C and D, overlapping identifications are denoted by a black box, and unique identifications are in gray. The total number of overlapping
identifications can be found at the top of the bar in text. The rightmost bars in the top graphs of C and D represent total identifications found in
Matrigel™ (11) and the H9 hESC secretome (29).
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because of the extensive overlap between the proteins in
conditioned Matrigel™ and commercial Matrigel™. The overlap between the three individual conditioned Matrigel™ datasets is ⬃35% based on protein identifiers after gene ontology
filtering (Fig. 4B). However, coverage between biological replicates of the same cell line using the identical fractionation
methods overlapped a minimum of 71% across the samples
in the experiment. The consistencies between biological replicates from single stem cell lines illustrate the reproducibility
of not only the proteomics method, but also the conditioned
Matrigel™ assay itself.
The proteomics data from analysis of conditioned Matrigel™ from hESCs and hiPSCs indicate that numerous cellline-specific factors were deposited based on comparisons
between the protein lists. In comparisons of core ECM proteins, isoforms of fibronectin and laminins and heparan sulfate
proteoglycan linked proteins were present at similar abundance levels based on the number of unique peptides in
conditioned Matrigel™ from H9 and BJ-1D cell lines. However, BJ-1D conditioned Matrigel™ was enriched by matrix
remodeling factors, such as matrix metalloproteinase-14 and
-15. Conditioned Matrigel™ derived from CA1 hESCs was
found to contain multiple collagen and laminin isoforms not
identified in the matrices from the other stem cell lines. Low
abundance factors such as soluble frizzled related proteins
(sFRPs) 1 and 2 and Lefty A and B were identified in conditioned Matrigel™ from all cell lines. Others, such as connective tissue growth factor (CTGF), were identified in conditioned Matrigel™ from both hESC lines, but not in that from
BJ-1D hiPSCs. In addition, other low abundance factors such
as Cerberus and fibroblast growth factor-15 were identified
only in CA1 conditioned Matrigel™.
Secretome Analysis of the hESC and hiPSC Microenvironment—To further validate and enrich for candidates in the
conditioned Matrigel™ data, a comparison was performed
with a previously published proteomics screen of the H9
hESC-secretome obtained from MS analysis of hESC-conditioned medium (29). We performed a re-analysis of the H9
hESC-secretome raw dataset with the same software (PEAKS
5.3) used to process the conditioned Matrigel™ data to facilitate comparison and minimize variability from protein assignments or identifiers. Comparison with the H9 hESC-secretome protein identifiers revealed 73%, 55%, and 54% overlap
between the unfiltered and 77%, 72%, and 68% between the
filtered H9, CA1, and BJ-1D conditioned Matrigel™ datasets,
respectively (Fig. 4D). The reduced similarity between the CA1
and BJ-1D conditioned Matrigel™ datasets and the H9 hESCsecretome further highlights the cell-line-specific differences
between these hESCs and hiPSCs. However, the overall similarity with the hESC secretome highlights the extracellular
nature of the conditioned Matrigel™ data set.
Further examination of the H9 hESC-secretome and conditioned Matrigel™ data revealed that many core ECM proteins,
such as fibronectin, collagen, and laminin isoforms, were
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found in all of the datasets. However, most were significantly
more abundant in the H9 hESC-secretome based on the
numbers of unique peptides identified. Other factors, such as
sFRP1 and CTGF, were also found in common between the
conditioned Matrigel™ and H9 hESC-secretome datasets.
However, these proteins were not found to have a higher
abundance in the H9 hESC-secretome based on unique peptide identifications. Additionally, other factors, such as the
Lefty A and B proteins, were not identified in our reanalyzed
H9 hESC-secretome dataset. These differences illustrate that
factors identified only in the conditioned Matrigel™ potentially
have an ECM-specific role in the microenvironment. Additionally, similarities between the H9 hESC-secretome and conditioned Matrigel™ data suggest that overlapping factors might
function in both soluble and insoluble portions of the
microenvironment.
Stem Cell Factors Identified in Conditioned MatrigelTM—
Proteomic investigation of the conditioned Matrigel™ dataset
revealed the presence of numerous hESC and hiPSC regulatory proteins. In order to enrich for hESC and hiPSC derived
proteins that facilitate the maintenance of an undifferentiated
state on conditioned Matrigel™, we opted to focus on only
those classified as extracellular or cell surface by gene ontology. Within this filtered dataset we found many essential core
ECM proteins that are also present in commercial Matrigel™
preparations (Fig. 5A). Further investigation of the filtered
conditioned Matrigel™ dataset revealed the presence of numerous factors with potential roles in hESC and hiPSC pluripotency (Fig. 5B). These included regulators of TGF-␤/Nodal
and Wnt signaling pathways, Lefty A/B, Cerberus, and
sFRP1/2. Other identified factors, such as hepatoma-derived
growth factor and CTGF, are of particular interest because of
their relevance in the biology of cancer cells (30, 31). Interestingly, after pathway analysis of the filtered datasets, we observed a significant enrichment for molecules involved in cell
motility, apoptosis, and invasion of cancer cells (Fig. 5C).
Several of these have previously been found in proteomic
screens of MEF and hESC-conditioned medium (29). However, their detection in conditioned Matrigel™ suggests that
the ECM is playing a role in their activity.
DISCUSSION

In this study we have employed a SILAC MS-based proteomics approach to reveal, for the first time, the components
of hESC- and hiPSC-derived conditioned Matrigel™. With this
approach, we have identified numerous factors with recognized roles in hESC and hiPSC pluripotency, as well as several
others not yet described. We observed that growth on stemcell-derived conditioned Matrigel™ in the absence of bFGF
promotes the maintenance of an undifferentiated state in
hESCs. This indicates that hESCs are depositing factors in the
matrix that can prevent stem cell differentiation and promote
self-renewal. Although previous studies have identified candidate proteins in the hESC microenvironment through the
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FIG. 5. Proteins and pathways identified in conditioned Matrigel™ from hESCs and hiPSCs. Conditioned Matrigel™ was analyzed using
an iterative exclusion MS proteomics-based approach. Proteins were identified using PEAKS 5.3 software. A, subset of the core ECM proteins
found in conditioned Matrigel™ that were also identified in a previous proteomic analysis of commercial Matrigel™ (11). In the case of collagen,
the top isoform was chosen. B, growth factors and proteins known to regulate core hESC and hiPSC pluripotency pathways found in
conditioned Matrigel™. Asterisks indicate when a protein was identified as a single peptide hit. Only proteins with two unique peptides are
retained, such that these single peptide hits are not included in the final dataset. C, pathway analysis performed using Ingenuity Systems
software. The top biological functions identified in all three cell lines were related to cellular movement, growth, and death or invasion of tumor
cell lines. Number of molecules denotes the number of candidate proteins identified as being involved with that function found in our dataset.
Black boxes represent the -log(p value) for the probability of identifying these pathways as being enriched in our dataset by chance.

analysis of conditioned medium, none have focused on proteins deposited in the ECM by pluripotent stem cells. Therefore, the methodology and the information within the dataset
presented here are of substantial importance in promoting a
comprehensive understanding of the hESC and hiPSC in vitro
microenvironment.
The presence of core ECM components in conditioned
Matrigel™, such as isoforms of fibronectin, collagen, and
laminin, illustrates that hESCs and hiPSCs generate a selfsupportive niche for attachment and proliferation. All three of
these matrix proteins have been shown to sustain the growth
of hESCs and hiPSCs when used as the sole growth support
(10, 12, 32–34). These core proteins regulate critical cellular
processes such as cell attachment through integrin binding.
Integrin interactions can mediate signal transduction responses similar to those triggered by soluble ligands (35, 36).
Therefore, hESCs and hiPSCs potentially utilize these interactions to regulate a diverse array of cellular functions. It is
likely that the presence of multiple core ECM proteins in
hESC- and hiPSC-supportive matrices such as Matrigel™
engages a complement of integrin-mediated events that collectively facilitate hESC and hiPSC growth (10, 37).
The identification of multiple growth factors and their binding partners in conditioned Matrigel™ highlights another potential function for these core ECM proteins in the matrix as a
reservoir for mitogenic and morphogenic factors. The ECM
has been proposed to contribute to the regulation of growth
factor signaling in the microenvironment (reviewed in Ref. 9).
Central to this function is the presence of specialized domains
on fibronectin and laminin designed to bind growth factors
such as epidermal growth factor, hepatocyte growth factor,
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and platelet derived growth factor. Fibronectin, for example,
contributes to TGF-␤ signaling through interaction with latentTGF-␤ binding proteins (38, 39). Binding between growth
factors and these glycoproteins can also be mediated by
interactions with heparan sulfate, a molecule that has been
shown to be beneficial for the maintenance of hESCs and
hiPSCs (9, 40). The result of these interactions implicates the
ECM in the orchestration of cellular processes through the
binding and regulation of growth factors.
Controlling the activity and concentration of growth factors
present in the microenvironment is critical for maintenance of
the hESC and hiPSC state. We identified proteins that regulate Wnt, TGF-␤ (through Activin/Nodal), and BMP signaling
pathways in conditioned Matrigel™. The sFRP1 and sFRP2
proteins have active roles in numerous cell systems, primarily
in the regulation of canonical Wnt signaling (reviewed in Ref.
41). Wnt signaling through the canonical pathway is important
for the maintenance of mESC and hESC self-renewal and
pluripotency (42– 44). In a recent study comparing 59 different
hESC lines, a positive correlation between Nanog and sFRP2
gene expression was observed (45). Additionally, sFRP2 was
identified as potentially regulated by Nanog in ChIP analyses
of hESCs (46). The C-terminal netrin domain on sFRP1 and
sFRP2 is known to confer heparin-binding properties that
potentially regulate the activity of the parent protein (47, 48).
Lefty A and B regulate TGF-␤ signaling through antagonism of
the activating protein Nodal (49). Activin/Nodal mediated signaling is one of the core pathways critical for the maintenance
of self-renewal and pluripotency of hESCs and hiPSCs (15,
16, 50). Interestingly, Lefty was previously observed to mediate metastatic melanoma cellular reprogramming on condi-
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tioned Matrigel™ (14). The presence of Lefty and sFRP proteins in conditioned Matrigel™ indicates that the ECM might
function to regulate these pathways.
Previous studies of ESC-derived matrix proteins have focused on the antagonism of the BMP pathway using Gremlin
(17). The inhibition of BMP mediated signaling promotes the
maintenance of hESC pluripotency (51). The activation of
SMAD (SMA mothers against decapentalegic) 1/5/8 mediated
gene expression following hESC exposure to BMP ligands
has been implicated in the differentiation of hESCs (16, 50).
Cerberus is an inhibitor of BMP mediated activation that acts
through antagonism of BMP4 (52, 53). Interestingly, Cerberus
has also been shown to inhibit Nodal and Wnt signaling
pathways (53, 54). The microenvironment is considered to
effect cellular change by providing a reservoir for growth
factors, morphogens, and cytokines. Given such, it is likely
that the core pathways we have identified here function together in conditioned Matrigel™ to generate a supportive
environment. Indeed, multiple levels of cross-talk have been
suggested among the FGF/TGF-␤/Wnt pathways (55, 56).
Currently, there is significant interest within the scientific
community in assessing the equivalency of hESCs and
hiPSCs based on multiple genomic, proteomic, and developmental criteria (57, 58). However, these studies have revealed
numerous differences between individual hESC and hiPSC
lines (59). In this study, although the conditioned Matrigel™
datasets were found to contain numerous proteins unique to
a single cell line, we did not observe a significant enrichment
in factors contributing to any specific pathway or process
when we focused on gene-ontology-filtered ECM proteins.
These findings indicate that in the culture system utilized for
this analysis, the stem-cell-deposited contribution to the microenvironment is highly similar in the individual hESC and
hiPSC lines tested. However, as has recently been demonstrated in large-scale comparative analyses of hESC and
hiPSCs, the ability to characterize differences between stem
cell proteomes is dependent on the sampling of a sufficient
number of cell lines (58). Expansion of the analysis performed
here to include an increased number of cell lines could potentially facilitate comparative analysis of hESC and hiPSC
conditioned Matrigel™. The inclusion of additional pluripotent
stem cell lines would also aid in the validation of deposited
proteins as opposed to those originating from cellular lysis
during the generation of conditioned Matrigel™.
The contamination of conditioned Matrigel™ by intracellular
proteins highlights the primary technical challenge of this
work going forward. Comparisons with datasets of secreted
proteins, such as the H9 hESC-secretome, give confidence
that the proteins found in conditioned Matrigel™ are truly
secreted. However, the limited specificity of gene ontology
assignments renders bioinformatic confirmation challenging.
In addition, the high abundance proteins present in Matrigel™
interfere with biological target validation of stem cell proteins
using assays such as immunofluorescence because of off-
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target interactions with the matrix. Analysis of conditioned
Matrigel™ in a defined growth system based on alternative
matrices such as fibronectin, vitronectin, or synthetic growth
surfaces could potentially facilitate the validation of identified
candidates for true localization and function through the minimization of background interactions. The recent development
of spotted matrix microarrays is an attractive alternative matrix support for use in combination with MS-based proteomics
analysis of conditioned Matrigel™ (60). In addition to supporting high-throughput screening of identified proteins from MS,
these methods permit colony-specific screening. Morphogen
gradients have been observed within individual stem cell colonies that will be masked in population-level analysis (20).
Direct analysis of colony-specific matrix interactions with MSbased proteomics can potentially provide valuable insight into
the stem cell microenvironment.
In conclusion, we have developed a technique that allows
the characterization of factors deposited by cells into complex
ECMs such as Matrigel™. Using this innovative approach, we
confirmed the presence of key pluripotency regulators such
as Lefty in stem cell conditioned matrices. In addition, we
identified other proteins, such as sFRP1/2, that could play
important roles in the regulation of stem fate. The constituents
of the ECM are largely unknown because of the complexity of
this fraction, especially when matrices such as Matrigel™ are
used as support. The new method presented in this work can
be used to characterize other ECMs (e.g. cancer cells) so that
key regulatory extracellular proteins can be identified.
Acknowledgments—C.H. is a recipient of an NSERC Canada Graduate Scholarship Doctoral Award. We are grateful to Courtney Brooks
for MEF cell culture and conditioning.
* This work was supported by a grant from the NSERC Discovery
program to G.L. and by grants from CIHR to W.L.S. (Grant No.
MOP-89910), L.-M.P., and D.H.B.
□
S This article contains supplemental material.
** To whom correspondence should be addressed: Dr. Gilles A.
Lajoie, Don Rix Protein Identification Facility, Department of Biochemistry, Schulich School of Medicine and Dentistry, University of
Western Ontario, London, ON, Canada, N6A 5C1. Tel.: (519) 6616054; Fax: (519) 661-3954; E-mail: glajoie@uwo.ca.
REFERENCES
1. Li, L., and Xie, T. (2005) Stem cell niche: structure and function. Annu. Rev.
Cell Dev. Biol. 21, 605– 631
2. Spradling, A., Drummond-Barbosa, D., and Kai, T. (2001) Stem cells find
their niche. Nature 414, 98 –104
3. Watt, F. M., and Hogan, B. L. M. (2000) Out of Eden: stem cells and their
niches. Science 287, 1427–1430
4. Chin, A. C. P., Fong, W. J., Goh, L. T., Philp, R., Oh, S. K. W., and Choo,
A. B. H. (2007) Identification of proteins from feeder conditioned medium
that support human embryonic stem cells. J. Biotechnol. 130, 320 –328
5. Lim, J. W. E., and Bodnar, A. (2002) Proteome analysis of conditioned
medium from mouse embryonic fibroblast feeder layers which support
the growth of human embryonic stem cells. Proteomics 2, 1187–1203
6. Prowse, A. B. J., McQuade, L. R., Bryant, K. J., Marcal, H., and Gray, P. P.
(2007) Identification of potential pluripotency determinants for human
embryonic stem cells following proteomic analysis of human and mouse
fibroblast conditioned media. J. Proteome Res. 6, 3796 –3807
7. Prowse, A. B. J., McQuade, L. R., Bryant, K. J., Van Dyk, D. D., Tuch, B. E.,

Molecular & Cellular Proteomics 11.12

Proteomics of Human Stem Cell Derived Matrices

8.

9.
10.

11.

12.

13.

14.

15.

16.

17.

18.

19.

20.

21.

22.

23.

24.

25.

26.

and Gray, P. P. (2005) A proteome analysis of conditioned media from
human neonatal fibroblasts used in the maintenance of human embryonic stem cells. Proteomics 5, 978 –989
Kleinman, H. K., McGarvey, M. L., Liotta, L. A., Robey, P. G., Tryggvason,
K., and Martin, G. R. (1982) Isolation and characterization of type IV
procollagen, laminin, and heparan sulfate proteoglycan from the EHS
sarcoma. Biochemistry 21, 6188 – 6193
Hynes, R. O. (2009) The extracellular matrix: not just pretty fibrils. Science
326, 1216 –1219
Hakala, H., Rajala, K., Ojala, M., Panula, S., Areva, S., Kellomaki, M.,
Suuronen, R., and Skottman, H. (2009) Comparison of biomaterials and
extracellular matrices as a culture platform for multiple, independently
derived human embryonic stem cell lines. Tissue Eng. Part A 15,
1775–1785
Hughes, C. S., Postovit, L. M., and Lajoie, G. A. (2010) Matrigel: a complex
protein mixture required for optimal growth of cell culture. Proteomics
10, 1886 –1890
Hughes, C. S., Radan, L., Betts, D., Postovit, L. M., and Lajoie, G. A. (2011)
Proteomic analysis of extracellular matrices used in stem cell culture.
Proteomics 11, 3983–3991
Postovit, L. M., Seftor, E. A., Seftor, R. E., and Hendrix, M. J. (2006) A
three-dimensional model to study the epigenetic effects induced by the
microenvironment of human embryonic stem cells. Stem Cells 24,
501–505
Postovit, L. M., Margaryan, N. V., Seftor, E. A., Kirschmann, D. A., Lipavsky,
A., Wheaton, W. W., Abbott, D. E., Seftor, R. E., and Hendrix, M. J. (2008)
Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc. Natl. Acad. Sci. U.S.A.
105, 4329 – 4334
Besser, D. (2004) Expression of nodal, lefty-a, and lefty-B in undifferentiated human embryonic stem cells requires activation of Smad2/3. J. Biol.
Chem. 279, 45076 – 45084
Vallier, L., Alexander, M., and Pedersen, R. A. (2005) Activin/Nodal and FGF
pathways cooperate to maintain pluripotency of human embryonic stem
cells. J. Cell Sci. 118, 4495– 4509
Kim, M. O., Kim, S. H., Oi, N., Lee, M. H., Yu, D. H., Kim, D. J., Cho, E. J.,
Bode, A. M., Cho, Y. Y., Bowden, T. G., and Dong, Z. (2011) Embryonic
stem-cell-preconditioned microenvironment induces loss of cancer cell
properties in human melanoma cells. Pigment Cell Melanoma Res. 24,
922–931
Ong, S. E., Blagoev, B., Kratchmarova, I., Kristensen, D. B., Steen, H.,
Pandey, A., and Mann, M. (2002) Stable isotope labeling by amino acids
in cell culture, SILAC, as a simple and accurate approach to expression
proteomics. Mol. Cell. Proteomics 1, 376 –386
Seguin, C. A., Draper, J. S., Nagy, A., and Rossant, J. (2008) Establishment
of endoderm progenitors by SOX transcription factor expression in human embryonic stem cells. Cell Stem Cell 3, 182–195
Peerani, R., Rao, B. M., Bauwens, C., Yin, T., Wood, G. A., Nagy, A.,
Kumacheva, E., and Zandstra, P. W. (2007) Niche-mediated control of
human embryonic stem cell self-renewal and differentiation. EMBO J. 26,
4744 – 4755
Hotta, A., Cheung, A. Y., Farra, N., Garcha, K., Chang, W. Y., Pasceri, P.,
Stanford, W. L., and Ellis, J. (2009) EOS lentiviral vector selection system
for human induced pluripotent stem cells. Nat. Protoc. 4, 1828 –1844
Bendall, S. C., Hughes, C., Stewart, M. H., Doble, B., Bhatia, M., and Lajoie,
G. A. (2008) Prevention of amino acid conversion in SILAC experiments
with embryonic stem cells. Mol. Cell. Proteomics 7, 1587–1597
Ma, B., Zhang, K. Z., Hendrie, C., Liang, C. Z., Li, M., Doherty-Kirby, A., and
Lajoie, G. (2003) PEAKS: powerful software for peptide de novo sequencing by tandem mass spectrometry. Rapid Commun. Mass Spectrom. 17, 2337–2342
Zhang, J., Xin, L., Shan, B., Chen, W., Xie, M., Yuen, D., Zhang, W., Zhang,
Z., Lajoie, G. A., and Ma, B. PEAKS DB: de novo sequencing assisted
database search for sensitive and accurate peptide identification. Mol.
Cell. Proteomics 4, 1– 8
Bhatia, V. N., Perlman, D. H., Costello, C. E., and McComb, M. E. (2009)
Software tool for researching annotations of proteins: open-source protein annotation software with data visualization. Anal. Chem. 81,
9819 –9823
Hendrix, M. J., Seftor, E. A., Seftor, R. E., Kasemeier-Kulesa, J., Kulesa,
P. M., and Postovit, L. M. (2007) Reprogramming metastatic tumour cells

Molecular & Cellular Proteomics 11.12

with embryonic microenvironments. Nat. Rev. Cancer 7, 246 –255
27. Wang, L., Schulz, T. C., Sherrer, E. S., Dauphin, D. S., Shin, S., Nelson,
A. M., Ware, C. B., Zhan, M., Song, C. Z., Chen, X., Brimble, S. N.,
McLean, A., Galeano, M. J., Uhl, E. W., D’Amour, K. A., Chesnut, J. D.,
Rao, M. S., Blau, C. A., and Robins, A. J. (2007) Self-renewal of human
embryonic stem cells requires insulin-like growth factor-1 receptor and
ERBB2 receptor signaling. Blood 110, 4111– 4119
28. Wang, S., Tian, R., Li, L., Figeys, D., and Wang, L. (2011) An enhanced
chemically defined SILAC culture system for quantitative proteomics
study of human embryonic stem cells. Proteomics 11, 4040 – 4046
29. Bendall, S. C., Hughes, C., Campbell, J. L., Stewart, M. H., Pittock, P., Liu,
S., Bonneil, E., Thibault, P., Bhatia, M., and Lajoie, G. A. (2009) An
enhanced mass spectrometry approach reveals human embryonic stem
cell growth factors in culture. Mol. Cell. Proteomics 8, 421– 432
30. Chu, C. Y., Chang, C. C., Prakash, E., and Kuo, M. L. (2008) Connective
tissue growth factor (CTGF) and cancer progression. J. Biomed. Sci. 15,
675– 685
31. Everett, A. D., and Bushweller, J. (2003) Hepatoma derived growth factor is
a nuclear targeted mitogen. Curr. Drug Targets 4, 367–371
32. Miyazaki, T., Futaki, S., Hasegawa, K., Kawasaki, M., Sanzen, N., Hayashi,
M., Kawase, E., Sekiguchi, K., Nakatsuji, N., and Suemori, H. (2008)
Recombinant human laminin isoforms can support the undifferentiated
growth of human embryonic stem cells. Biochem. Biophys. Res. Commun. 375, 27–32
33. Baxter, M. A., Camarasa, M. V., Bates, N., Small, F., Murray, P., Edgar, D.,
and Kimber, S. J. (2009) Analysis of the distinct functions of growth
factors and tissue culture substrates necessary for the long-term selfrenewal of human embryonic stem cell lines. Stem Cell Res. 1, 28 –38
34. Furue, M. K., Na, J., Jackson, J. P., Okamoto, T., Jones, M., Baker, D.,
Hata, R., Moore, H. D., Sato, J. D., and Andrews, P. W. (2008) Heparin
promotes the growth of human embryonic stem cells in a defined serumfree medium. Proc. Natl. Acad. Sci. U.S.A. 105, 13409 –13414
35. Berrier, A. L., and Yamada, K. M. (2007) Cell-matrix adhesion. J. Cell.
Physiol. 213, 565–573
36. Legate, K. R., Wickstrom, S. A., and Fassler, R. (2009) Genetic and cell
biological analysis of integrin outside-in signaling. Genes Dev. 23,
397– 418
37. Ludwig, T. E., Levenstein, M. E., Jones, J. M., Berggren, W. T., Mitchen,
E. R., Frane, J. L., Crandall, L. J., Daigh, C. A., Conard, K. R., Piekarczyk,
M. S., Llanas, R. A., and Thomson, J. A. (2006) Derivation of human
embryonic stem cells in defined conditions. Nat. Biotechnol. 24, 185–187
38. Munger, J. S., and Sheppard, D. (2011) Cross talk among TGF-beta signaling pathways, integrins, and the extracellular matrix. Cold Spring
Harb. Perspect. Biol. 3, 1–17
39. Ramirez, F., and Rifkin, D. B. (2009) Extracellular microfibrils: contextual
platforms for TGFbeta and BMP signaling. Curr. Opin. Cell Biol. 21,
616 – 622
40. Sasaki, N., Okishio, K., Ui-Tei, K., Saigo, K., Kinoshita-Toyoda, A., Toyoda,
H., Nishimura, T., Suda, Y., Hayasaka, M., Hanaoka, K., Hitoshi, S.,
Ikenaka, K., and Nishihara, S. (2008) Heparan sulfate regulates selfrenewal and pluripotency of embryonic stem cells. J. Biol. Chem. 283,
3594 –3606
41. Esteve, P., and Bovolenta, P. (2010) The advantages and disadvantages of
sfrp1 and sfrp2 expression in pathological events. Tohoku J. Exp. Med.
221, 11–17
42. ten Berge, D., Kurek, D., Blauwkamp, T., Koole, W., Maas, A., Eroglu, E.,
Siu, R. K., and Nusse, R. (2011) Embryonic stem cells require Wnt
proteins to prevent differentiation to epiblast stem cells. Nat. Cell Biol.
13, 1070 –1075
43. Sato, N., Meijer, L., Skaltsounis, L., Greengard, P., and Brivanlou, A. H.
(2004) Maintenance of pluripotency in human and mouse embryonic
stem cells through activation of Wnt signaling by a pharmacological
GSK-3-specific inhibitor. Nat. Med. 10, 55– 63
44. Dravid, G., Ye, Z., Hammond, H., Chen, G., Pyle, A., Donovan, P., Yu, X.,
and Cheng, L. (2005) Defining the role of Wnt/beta-catenin signaling in
the survival, proliferation, and self-renewal of human embryonic stem
cells. Stem Cells 23, 1489 –1501
45. Adewumi, O., Aflatoonian, B., Ahrlund-Richter, L., Amit, M., Andrews,
P. W., Beighton, G., Bello, P. A., Benvenisty, N., Berry, L. S., Bevan, S.,
Blum, B., Brooking, J., Chen, K. G., Choo, A. B., Churchill, G. A., Corbel,
M., Damjanov, I., Draper, J. S., Dvorak, P., Emanuelsson, K., Fleck, R. A.,

1935

Proteomics of Human Stem Cell Derived Matrices

46.

47.

48.

49.
50.

Ford, A., Gertow, K., Gertsenstein, M., Gokhale, P. J., Hamilton, R. S.,
Hampl, A., Healy, L. E., Hovatta, O., Hyllner, J., Imreh, M. P., ItskovitzEldor, J., Jackson, J., Johnson, J. L., Jones, M., Kee, K., King, B. L.,
Knowles, B. B., Lako, M., Lebrin, F., Mallon, B. S., Manning, D., Mayshar,
Y., McKay, R. D., Michalska, A. E., Mikkola, M., Mileikovsky, M., Minger,
S. L., Moore, H. D., Mummery, C. L., Nagy, A., Nakatsuji, N., O’Brien,
C. M., Oh, S. K., Olsson, C., Otonkoski, T., Park, K. Y., Passier, R., Patel,
H., Patel, M., Pedersen, R., Pera, M. F., Piekarczyk, M. S., Pera, R. A.,
Reubinoff, B. E., Robins, A. J., Rossant, J., Rugg-Gunn, P., Schulz, T. C.,
Semb, H., Sherrer, E. S., Siemen, H., Stacey, G. N., Stojkovic, M.,
Suemori, H., Szatkiewicz, J., Turetsky, T., Tuuri, T., van den Brink, S.,
Vintersten, K., Vuoristo, S., Ward, D., Weaver, T. A., Young, L. A., and
Zhang, W. (2007) Characterization of human embryonic stem cell lines by
the International Stem Cell Initiative. Nat. Biotechnol. 25, 803– 816
Boyer, L. A., Lee, T. I., Cole, M. F., Johnstone, S. E., Levine, S. S., Zucker,
J. P., Guenther, M. G., Kumar, R. M., Murray, H. L., Jenner, R. G., Gifford,
D. K., Melton, D. A., Jaenisch, R., and Young, R. A. (2005) Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122,
947–956
Uren, A., Reichsman, F., Anest, V., Taylor, W. G., Muraiso, K., Bottaro,
D. P., Cumberledge, S., and Rubin, J. S. (2000) Secreted frizzled-related
protein-1 binds directly to Wingless and is a biphasic modulator of Wnt
signaling. J. Biol. Chem. 275, 4374 – 4382
Lee, J. L., Lin, C. T., Chueh, L. L., and Chang, C. J. (2004) Autocrine/
paracrine secreted frizzled-related protein 2 induces cellular resistance
to apoptosis: a possible mechanism of mammary tumorigenesis. J. Biol.
Chem. 279, 14602–14609
Schier, A. F. (2003) Nodal signaling in vertebrate development. Annu. Rev.
Cell Dev. Biol. 19, 589 – 621
James, D., Levine, A. J., Besser, D., and Hemmati-Brivanlou, A. (2005) TGF
beta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem. Development 132, 1273–1282

1936

51. Xu, R. H., Peck, R. M., Li, D. S., Feng, X., Ludwig, T., and Thomson, J. A.
(2005) Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat. Methods 2, 185–190
52. Belo, J. A., Bachiller, D., Agius, E., Kemp, C., Borges, A. C., Marques, S.,
Piccolo, S., and De Robertis, E. M. (2000) Cerberus-like is a secreted
BMP and nodal antagonist not essential for mouse development. Genesis 26, 265–270
53. Piccolo, S., Agius, E., Leyns, L., Bhattacharyya, S., Grunz, H., Bouwmeester, T., and De Robertis, E. M. (1999) The head inducer Cerberus is
a multifunctional antagonist of Nodal, BMP and Wnt signals. Nature 397,
707–710
54. Kawano, Y., and Kypta, R. (2003) Secreted antagonists of the Wnt signalling pathway. J. Cell Sci. 116, 2627–2634
55. Guo, X., and Wang, X. F. (2009) Signaling cross-talk between TGF-beta/
BMP and other pathways. Cell Res. 19, 71– 88
56. Singh, A. M., Reynolds, D., Cliff, T., Ohtsuka, S., Mattheyses, A. L., Sun, Y.,
Menendez, L., Kulik, M., and Dalton, S. (2012) Signaling network crosstalk in human pluripotent cells: a SMAD2/3-regulated switch that controls the balance between self-renewal and differentiation. Cell Stem Cell
10, 312–326
57. Narsinh, K. H., Plews, J., and Wu, J. C. (2011) Comparison of human
induced pluripotent and embryonic stem cells: fraternal or identical
twins? Mol. Ther. 19, 635– 638
58. Phanstiel, D. H., Brumbaugh, J., Wenger, C. D., Tian, S., Probasco, M. D.,
Bailey, D. J., Swaney, D. L., Tervo, M. A., Bolin, J. M., Ruotti, V., Stewart,
R., Thomson, J. A., and Coon, J. J. (2011) Proteomic and phosphoproteomic comparison of human ES and iPS cells. Nat. Methods 8, 821– 827
59. Allegrucci, C., and Young, L. E. (2007) Differences between human embryonic stem cell lines. Hum. Reprod. Update 13, 103–120
60. Gobaa, S., Hoehnel, S., Roccio, M., Negro, A., Kobel, S., and Lutolf, M. P.
(2011) Artificial niche microarrays for probing single stem cell fate in high
throughput. Nat. Methods 8, 949 –955

Molecular & Cellular Proteomics 11.12

